Skip to content
  • ABOUT
        • MISSION/HISTORY
        • DIRECTORS/STAFF
        • SUPPORT
        • INTERNSHIPS
        • FINANCIAL INFORMATION
        • JOBS
        • CONTACT US
  • WASTEWATCHER
  • MEDIA
        • COMMENTARY
        • PRESS RELEASES
        • VIDEOS
  • ISSUES
    • CONGRESSIONAL PIG BOOK
      • EARMARK DATABASE
      • PRIME CUTS
      • ISSUE BRIEFS
      • AGENCY COMMENTS
    • DEFENSE
      • AVIATION & SPACE
      • F-35 JOINT STRIKE FIGHTER
      • PROCUREMENT
    • INNOVATION & TECHNOLOGY POLICY CENTER
      • ANTITRUST
      • ARTIFICIAL INTELLIGENCE
      • BIOPHARMACEUTICALS
      • INTELLECTUAL PROPERTY
      • PRIVACY
      • TECHNOLOGY AND INNOVATION
      • TELECOMMUNICATIONS
    • GENERAL WASTE
      • AGRICULTURE REFORM
      • POSTAL SERVICE
      • TAXES
      • TRANSPORTATION
    • HEALTH AND SCIENCE
      • PRICE CONTROLS
      • GOVERNMENT RUN HEALTHCARE
      • 340B DRUG DISCOUNT PROGRAM
      • PHARMACY BENEFIT MANAGERS
      • TOBACCO HARM REDUCTION
    • STATE ISSUES
  • ITPC
        • ANTITRUST
        • ARTIFICIAL INTELLIGENCE
        • BIOPHARMACEUTICALS
        • INTELLECTUAL PROPERTY
        • PRIVACY
        • TECHNOLOGY AND INNOVATION
        • TELECOMMUNICATIONS
  • CCAGW
DONATE
Facebook X-twitter Icon-instagram-1 Icon-youtube

340B

340B, Entitlements, General Waste, Healthcare, Pharmaceuticals

Price Controls on Medicaid Would Be Disastrous and Fail to Cut Wasteful Spending

May 4, 2025 Eric Maus

President Trump has made government efficiency a top priority.  These efforts include eliminating improper payments and ensuring that only those who are eligible for government programs receive the benefits, including Medicaid.  As President Trump said on “Meet the Press” on Sunday, May 4, 2025, “if illegal immigrants are in the mix, if people that aren’t […]

340B, Biopharmaceuticals, General Waste, Healthcare, Intellectual Property, International

Implementation of Drug Pricing EO Should Protect Innovation and IP

April 16, 2025 Thomas Schatz

President Trump’s EO addresses the dual objectives of lowering drug prices while promoting innovation and protecting IP

340B, General Waste, Healthcare

340B Must Be Reformed in the 119th Congress

February 12, 2025 Christina Smith

340B reform should not only should be acted on by Congress, but also reviewed by DOGE.

340B, General Waste

Hospitals Abuse 340B Program at the Expense of Vulnerable Patients

January 17, 2025 Christina Smith

The 340B Drug Pricing Program allows hospitals to prioritize profits over patients. 

340B, General Waste

New State Report Details Costs and Abuses of the 340B Drug Pricing Program

November 26, 2024 Thomas Schatz

Minnesota Department of Health 340B report is the first at the state level to show costs and abuses of the program.

340B, General Waste, Healthcare

340B Drug Discount Program is a Nightmare

October 11, 2024 Christina Smith

Like many other well-intended programs 340B has ended up both wasting money and failing to provide benefits for patients.

The Case for 340B Reform Is Made on Capitol Hill
Healthcare, 340B

The Case for 340B Reform Is Made on Capitol Hill

September 24, 2024 Thomas Schatz

At a Capitol Hill briefing on the urgent need for reforms to the 340B Drug Pricing Program, the case was made for prompt action to fix the program.  The event took place at the Senate Visitors Center on September 23, 2024, and was hosted by the Council for Citizens Against Government Waste (CCAGW). The panel […]

The 340B Drug Discount Program Needs an Overhaul
340B, General Waste, Healthcare

The 340B Drug Discount Program Needs an Overhaul

August 16, 2023 Christina Smith

CAGW has long been concerned with the misuse of the 340B Program.  

New Study Exposes More Exploitation and Waste in the 340B Drug Discount Program
340B, General Waste, Healthcare

New Study Exposes More Exploitation and Waste in the 340B Drug Discount Program

June 10, 2023 Christina Smith

A new study, “The 340B Drug Discount Program Exceeds $100B in 2022,” shows the program is misused.

Citizens Against Government Waste Releases Analysis of Minnesota Opioid Tax
340B, General Waste, Government Waste, Healthcare, Oversight, Pharmaceuticals

New Study Confirms 340B Program is Exploited

December 3, 2021 Elizabeth Wright

A new study, “340B and Health Equity: A Missed Opportunity in Medically Underserved Areas,” shows the program is misused.

Posts pagination

Previous 1 2 3 … 5 Next

Search

Citizens Against Government Waste works to eliminate waste, fraud, abuse, and mismanagement in government through research and public education.

  • ABOUT
  • WASTEWATCHER
  • MEDIA CENTER
  • ISSUES
  • ITPC
  • CCAGW
  • 1-800-USA-DEBT ®
  • MEDIA@CAGW.ORG
  • 317 MASSACHUSETTS AVENUE, N.E.
    SUITE 300
    WASHINGTON, D.C. 20002

© Citizens Against Government Waste